Fig. 2: Independent validation of better remission rate to sertraline treatment in slow-iAF subgroup in a randomized, double-blind, placebo-controlled trial.
Normalized remission rate in the low-decile subgroup for placebo and sertraline treatment arm after 8 or 16 weeks of treatment.
